The new regulatory move on brand name extension marks a significant step strengthening drug safety and reducing patient confusion in Indian pharma
Covid precautions have returned to focus after Andhra Pradesh reported two Covid deaths and eight active Covid cases.
India Creates Global First as CDSCO Clears Synthetic CBD Therapy with the approval of a prescription treatment for anxiety disorders.
Biogen’s continued focus on developing an effective alzhiemers drug reflects progress and uncertainty in the global fight against the disease
Generic Semaglutide has helped Sun Pharmaceutical Industries expand its global presence with a fresh regulatory win.
India is positioning medical research as a central pillar in its long-term strategy to achieve developed nation status by 2047
India’s healthcare system is set for a major boost through medical insurance expansion. The government is considering doubling coverage under Ayushman Bharat
COVID preparedness has become a key focus in Odisha after fresh COVID-19 cases were reported in neighboring Andhra Pradesh.
The Indian Pharma Industry is moving towards a biosimilars manufacturing growth phase. Earlier this year, India was the subject of a global collaboration that reflects growing international trust in its abilities
The Alzheimer's drug market is witnessing a significant strategic shift as Eisai and Biogen strengthen their competitive position. AS the new FDA approval allows at-home initiation of their therapy
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")